Ticker
RGNXCompany Name
REGENXBIO INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cash and Equivalents | Cash Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 81.59M | 0.68 | $ 119.54M |
3/31/2025 | $ 132.13M | 1.24 | $ 106.73M |
12/31/2024 | $ 59.56M | 0.58 | $ 103.19M |
9/30/2024 | $ 58.65M | 0.57 | $ 102.72M |
6/30/2024 | $ 59.8M | 0.61 | $ 98.27M |
3/31/2024 | $ 115M | 1.04 | $ 110.18M |
12/31/2023 | $ 36.55M | 0.28 | $ 130.27M |
9/30/2023 | $ 55.3M | 0.43 | $ 127.35M |
6/30/2023 | $ 70.86M | 0.6 | $ 117.89M |
3/31/2023 | $ 72.12M | 0.64 | $ 112.33M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for REGENXBIO INC is calculated as follows: CashnEq [ $ 94.55M ] / LiabilitesC [ $ 63.61M ]
(=) Cash Ratio [ 1.49 ]
Minimum
Dec 31, 2023
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.13K |
---|---|
min | 0 |
max | 2.69 |
average | 0.62 |
median | 0.39 |
std | 0.63 |